Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO21413-D1

Biomarker Field of development:

Oncology Therapy Area:

Methods and composition to identify and treat subjects resisting to

The present invention relates to a method for treating a subject suffering from a cancer comprising a step of administering said subject with a […]

BIO21444-D1

Biomarker Field of development:

Oncology Therapy Area:

Method Type of patent:

Methods and compositions for treating triple negative breast cancer

Inventors analyzed the prognostic value of tumor and stromal-derived SPARC in a large series that included 148 non-metastatic TNBC patients with a […]

BIO20332-D1

Biomarker Field of development:

Oncology Therapy Area:

Method Type of patent:

Methods for improving the efficacy of hdac inhibitor therapy and

Investigating the impact of Tau protein expression in cancer cell lines, Inventors have demonstrated that the Tau expression is associated with an […]

BIO20377-T1

Drug Field of development:

Oncology Therapy Area:

Method Type of patent:

Methods and pharmaceutical compositions for treating cancer

Tumour-specific molecular targets and alternative therapeutic strategies for triplenegative breast cancer (TNBC) are urgently needed. The protease […]

BIO19474-T1

Drug Field of development:

Oncology Therapy Area:

Target Type of patent:

Methods of treatment of cancer disease by targeting an epigenetic

The present invention relates to a method for preventing or treating a cancer disease by targeting the epigenetic factor Chromodomain on Y-like 2 […]

BIO21413-T1

Drug Field of development:

Oncology Therapy Area:

Method Type of patent:

Methods and composition to identify and treat subjects resisting to

The present invention relates to a method for treating a subject suffering from a cancer comprising a step of administering said subject with a […]

BIO14138-T1

Drug Field of development:

Oncology Therapy Area:

Product Type of patent:

Anti-cathepsin d human antibody for triple negative breast cancer

Inventors have generated two human anti-cath-D scFv fragments cloned in the human IgG1 ??format (F1 and E2) that efficiently bind to human and mouse […]

BIO17261-T1

Drug Field of development:

Oncology Therapy Area:

Method Type of patent:

A checkpoint kinase 1 inhibitor sensitises cancer cells to

The present invention relates to the field of cancer treatment. In this study, the inventors sought to investigate whether this antiproliferative […]

147

56

310

46

Our Technology Offers

Methods and composition to identify and treat subjects resisting to

Methods and compositions for treating triple negative breast cancer

Methods for improving the efficacy of hdac inhibitor therapy and

Methods and pharmaceutical compositions for treating cancer

Methods of treatment of cancer disease by targeting an epigenetic

Methods and composition to identify and treat subjects resisting to

Anti-cathepsin d human antibody for triple negative breast cancer

A checkpoint kinase 1 inhibitor sensitises cancer cells to

You might also be interested in

Methods and compositions for treating asthma and

Hepcidin antagonists for use in the treatment of

Methods for the treatment of th2-mediated diseases

Use of hif-1¿ stabilizing agents for the

Methods for the treatment of food allergy

Use of jak inhibitors for the treatment of painful

Methods and compositions for treatment of rac2

Methods and compositions for reparing airway

Methods and pharmaceutical compositions for the

Methods for diagnosis and monitoring of toxic

Use of let-7b or mir-21 inhibitors for the

Methods for the diagnosis, treatment and analysis